the village pharmacy (collingham) limited Company Information
Company Number
05381684
Website
www.collingham-notts.org.ukRegistered Address
5 hastings court, collingham, wetherby, LS22 5AW
Industry
Other human health activities
Telephone
01636893038
Next Accounts Due
December 2024
Group Structure
View All
Directors
Sara Pilcher19 Years
Shareholders
sara louise pilcher 50%
molly smith 50%
the village pharmacy (collingham) limited Estimated Valuation
Pomanda estimates the enterprise value of THE VILLAGE PHARMACY (COLLINGHAM) LIMITED at £532.8k based on a Turnover of £1.4m and 0.39x industry multiple (adjusted for size and gross margin).
the village pharmacy (collingham) limited Estimated Valuation
Pomanda estimates the enterprise value of THE VILLAGE PHARMACY (COLLINGHAM) LIMITED at £0 based on an EBITDA of £-57.1k and a 3.56x industry multiple (adjusted for size and gross margin).
the village pharmacy (collingham) limited Estimated Valuation
Pomanda estimates the enterprise value of THE VILLAGE PHARMACY (COLLINGHAM) LIMITED at £1.1m based on Net Assets of £477.7k and 2.32x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Village Pharmacy (collingham) Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
The Village Pharmacy (collingham) Limited Overview
The Village Pharmacy (collingham) Limited is a live company located in wetherby, LS22 5AW with a Companies House number of 05381684. It operates in the other human health activities sector, SIC Code 86900. Founded in March 2005, it's largest shareholder is sara louise pilcher with a 50% stake. The Village Pharmacy (collingham) Limited is a established, small sized company, Pomanda has estimated its turnover at £1.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Village Pharmacy (collingham) Limited Health Check
Pomanda's financial health check has awarded The Village Pharmacy (Collingham) Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
5 Regular
4 Weak
Size
annual sales of £1.4m, make it larger than the average company (£719.6k)
- The Village Pharmacy (collingham) Limited
£719.6k - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a similar rate (5.3%)
- The Village Pharmacy (collingham) Limited
5.3% - Industry AVG
Production
with a gross margin of 35.9%, this company has a comparable cost of product (35.9%)
- The Village Pharmacy (collingham) Limited
35.9% - Industry AVG
Profitability
an operating margin of -4.9% make it less profitable than the average company (6.1%)
- The Village Pharmacy (collingham) Limited
6.1% - Industry AVG
Employees
with 8 employees, this is below the industry average (19)
8 - The Village Pharmacy (collingham) Limited
19 - Industry AVG
Pay Structure
on an average salary of £24.6k, the company has an equivalent pay structure (£24.6k)
- The Village Pharmacy (collingham) Limited
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £171.9k, this is more efficient (£43.3k)
- The Village Pharmacy (collingham) Limited
£43.3k - Industry AVG
Debtor Days
it gets paid by customers after 46 days, this is later than average (22 days)
- The Village Pharmacy (collingham) Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 54 days, this is slower than average (18 days)
- The Village Pharmacy (collingham) Limited
18 days - Industry AVG
Stock Days
it holds stock equivalent to 25 days, this is more than average (9 days)
- The Village Pharmacy (collingham) Limited
9 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 135 weeks, this is average cash available to meet short term requirements (141 weeks)
135 weeks - The Village Pharmacy (collingham) Limited
141 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 22.1%, this is a similar level of debt than the average (21.7%)
22.1% - The Village Pharmacy (collingham) Limited
21.7% - Industry AVG
the village pharmacy (collingham) limited Credit Report and Business Information
The Village Pharmacy (collingham) Limited Competitor Analysis
Perform a competitor analysis for the village pharmacy (collingham) limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
the village pharmacy (collingham) limited Ownership
THE VILLAGE PHARMACY (COLLINGHAM) LIMITED group structure
The Village Pharmacy (Collingham) Limited has no subsidiary companies.
Ultimate parent company
THE VILLAGE PHARMACY (COLLINGHAM) LIMITED
05381684
the village pharmacy (collingham) limited directors
The Village Pharmacy (Collingham) Limited currently has 1 director, Ms Sara Pilcher serving since Mar 2005.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Sara Pilcher | United Kingdom | 60 years | Mar 2005 | - | Director |
THE VILLAGE PHARMACY (COLLINGHAM) LIMITED financials
The Village Pharmacy (Collingham) Limited's latest turnover from March 2023 is estimated at £1.4 million and the company has net assets of £477.7 thousand. According to their latest financial statements, The Village Pharmacy (Collingham) Limited has 8 employees and maintains cash reserves of £344.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 15,335 | 20,145 | 18,630 | 22,030 | 27,986 | 33,866 | 34,973 | 33,426 | 40,566 | 47,256 | 25,493 | 11,905 | 14,883 | 9,521 |
Intangible Assets | 10,000 | 15,000 | 20,000 | 25,000 | 30,000 | 35,000 | 40,000 | 45,000 | 50,000 | 55,000 | 60,000 | 65,000 | 70,000 | 75,000 |
Investments & Other | 7,903 | 7,903 | 55,403 | 62,903 | 62,903 | 62,903 | 62,903 | 62,903 | 57,748 | 57,748 | 57,748 | 57,748 | 57,648 | 57,548 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 33,238 | 43,048 | 94,033 | 109,933 | 120,889 | 131,769 | 137,876 | 141,329 | 148,314 | 160,004 | 143,241 | 134,653 | 142,531 | 142,069 |
Stock & work in progress | 60,627 | 52,946 | 48,382 | 58,273 | 54,151 | 54,264 | 65,291 | 76,513 | 61,452 | 61,755 | 61,962 | 69,226 | 62,402 | 60,631 |
Trade Debtors | 174,946 | 86,189 | 211,797 | 139,817 | 107,760 | 104,161 | 119,334 | 109,014 | 128,835 | 101,872 | 127,760 | 120,832 | 136,590 | 143,685 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 344,224 | 495,638 | 274,098 | 196,940 | 140,209 | 115,250 | 61,763 | 25,803 | 3,720 | 20,547 | 1,556 | 1,527 | 1,527 | 595 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 579,797 | 634,773 | 534,277 | 395,030 | 302,120 | 273,675 | 246,388 | 211,330 | 194,007 | 184,174 | 191,278 | 191,585 | 200,519 | 204,911 |
total assets | 613,035 | 677,821 | 628,310 | 504,963 | 423,009 | 405,444 | 384,264 | 352,659 | 342,321 | 344,178 | 334,519 | 326,238 | 343,050 | 346,980 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 132,260 | 147,002 | 137,745 | 103,299 | 73,608 | 77,454 | 96,891 | 89,801 | 83,372 | 91,496 | 148,949 | 89,655 | 94,498 | 105,299 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 132,260 | 147,002 | 137,745 | 103,299 | 73,608 | 77,454 | 96,891 | 89,801 | 83,372 | 91,496 | 148,949 | 89,655 | 94,498 | 105,299 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 3,052 | 4,010 | 3,701 | 4,156 | 3,711 | 5,745 | 4,255 | 5,368 | 6,505 | 7,304 | 4,151 | 1,221 | 0 | 0 |
total long term liabilities | 3,052 | 4,010 | 3,701 | 4,156 | 3,711 | 5,745 | 4,255 | 5,368 | 6,505 | 7,304 | 4,151 | 1,221 | 0 | 0 |
total liabilities | 135,312 | 151,012 | 141,446 | 107,455 | 77,319 | 83,199 | 101,146 | 95,169 | 89,877 | 98,800 | 153,100 | 90,876 | 94,498 | 105,299 |
net assets | 477,723 | 526,809 | 486,864 | 397,508 | 345,690 | 322,245 | 283,118 | 257,490 | 252,444 | 245,378 | 181,419 | 235,362 | 248,552 | 241,681 |
total shareholders funds | 477,723 | 526,809 | 486,864 | 397,508 | 345,690 | 322,245 | 283,118 | 257,490 | 252,444 | 245,378 | 181,419 | 235,362 | 248,552 | 241,681 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 4,810 | 6,300 | 4,657 | 5,669 | 6,996 | 8,466 | 8,744 | 8,357 | 10,143 | 11,816 | 6,373 | 2,978 | 3,722 | 2,381 |
Amortisation | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 |
Tax | ||||||||||||||
Stock | 7,681 | 4,564 | -9,891 | 4,122 | -113 | -11,027 | -11,222 | 15,061 | -303 | -207 | -7,264 | 6,824 | 1,771 | 60,631 |
Debtors | 88,757 | -125,608 | 71,980 | 32,057 | 3,599 | -15,173 | 10,320 | -19,821 | 26,963 | -25,888 | 6,928 | -15,758 | -7,095 | 143,685 |
Creditors | -14,742 | 9,257 | 34,446 | 29,691 | -3,846 | -19,437 | 7,090 | 6,429 | -8,124 | -57,453 | 59,294 | -4,843 | -10,801 | 105,299 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -958 | 309 | -455 | 445 | -2,034 | 1,490 | -1,113 | -1,137 | -799 | 3,153 | 2,930 | 1,221 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | -47,500 | -7,500 | 0 | 0 | 0 | 0 | 5,155 | 0 | 0 | 0 | 100 | 100 | 57,548 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -151,414 | 221,540 | 77,158 | 56,731 | 24,959 | 53,487 | 35,960 | 22,083 | -16,827 | 18,991 | 29 | 0 | 932 | 595 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -151,414 | 221,540 | 77,158 | 56,731 | 24,959 | 53,487 | 35,960 | 22,083 | -16,827 | 18,991 | 29 | 0 | 932 | 595 |
P&L
March 2023turnover
1.4m
+32%
operating profit
-66.9k
0%
gross margin
35.9%
+0.78%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
477.7k
-0.09%
total assets
613k
-0.1%
cash
344.2k
-0.31%
net assets
Total assets minus all liabilities
the village pharmacy (collingham) limited company details
company number
05381684
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
March 2005
age
19
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
5 hastings court, collingham, wetherby, LS22 5AW
last accounts submitted
March 2023
the village pharmacy (collingham) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to the village pharmacy (collingham) limited. Currently there are 1 open charges and 0 have been satisfied in the past.
the village pharmacy (collingham) limited Companies House Filings - See Documents
date | description | view/download |
---|